NCT01061840 2022-03-15Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced CancerGradalis, Inc.Phase 1 Completed100 enrolled
NCT01258868 2019-12-03Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasNational Institutes of Health Clinical Center (CC)Phase 1 Terminated44 enrolled